Intracellular Mis-Localization of Modified RNA Molecules and Non-Coding RNAs: Facts from Hematologic Malignancies.

Area of Science:

• Molecular Biology
• Epigenetics
• Hematology

Background:

• RNA molecules, including modified ribonucleotides and non-coding RNAs, are studied within the epigenome framework.
• RNA modifications are crucial for RNA translocation, stability, translation, and other cellular functions.
• The study of intercellular RNA compartmentalization is advancing, but its role in hematological malignancies requires further investigation.

Purpose of the Study:

• To review intracellular processes leading to ectopic RNA placement and their link to hematological malignancies.
• To highlight the crosstalk between mitochondrial and nuclear genomes concerning RNA mislocalization.
• To explore the potential of RNA technology for targeted therapies in hematology.

Main Methods:

• Review of current literature on RNA modifications, trafficking, and epigenetics.
• Analysis of the role of RNA molecule misplacement in disease pathogenesis.
• Discussion of technological advancements in studying RNA compartmentalization.

Main Results:

• Disrupted intracellular processes can cause ectopic RNA placement, influencing RNA modifications and non-coding RNA functions.
• Alterations in nuclear, cytoplasmic, and mitochondrial compartments can disorganize hematopoietic stem cell epigenomes, promoting malignancies.
• Crosstalk between mitochondrial and nuclear genomes and mislocalized RNA molecules play complex regulatory roles.

Conclusions:

• Ectopic RNA placement and epigenetic dysregulation are implicated in the development of hematological malignancies.
• Targeting RNA processes and their interactions offers a promising avenue for novel hematological therapies.